MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Sponsored by FastWave Medical
The Next Wave of Intravascular Lithotripsy: A Panel Interview on Advances in Treating Calcific PAD
With Arthur Lee, MD; Amir Kaki, MD; Miguel Montero-Baker, MD; Venkatesh Ramaiah, MD, FACS; and Peter Schneider, MD
Ask the Experts
What is one thing you have learned that you wish you knew the day you began planning your outpatient practice?
With Arthur Lee, MD, and Carlo A. Dall'Olmo, MD
MedAlliance Commences SELUTION4SFA IDE Trial
May 4, 2023—MedAlliance announced the commencement in the United States of the SELUTION4SFA study, which is evaluating the company’s Selution SLR sirolimus drug-eluting balloon (DEB) in the treatment of occlusive disease of the superficial femoral artery and proximal popliteal artery.
FastWave Raises Funds to Accelerate Development of IVL Systems to Treat Cardiovascular Calcium
December 16, 2024—FastWave Medical, a clinical-stage medical device company, announced the close of a $19 million funding round earlier this year, increasing the total capital invested into the company to over $40 million.
FastWave Announces Medical Advisor Appointments and Pipeline Update
March 6, 2024—FastWave Medical Inc., a device company focused the treatment of calcified cardiovascular disease through intravascular lithotripsy (IVL), recently announced the appointments of eight medical advisors.
Bard Begins Enrollment in Lutonix BTK Clinical Trial
June 4, 2013—Bard Peripheral Vascular (Tempe, AZ) announced commencement of enrollment in the Lutonix below-the-knee (BTK) clinical trial.
An Interview With Arthur C. Lee, MD
The interventional cardiologist shares his insights on below-the-knee interventions and the future of renal denervation and drug-coated balloon technologies.
Pedal Arch Revascularization
The rationale behind this procedure and tips from preprocedure planning to intervention.
By Arthur C. Lee, MD, and Matheen A. Khuddus, MD
Managing Perforations of the Superficial Femoral Artery
How to prevent and treat these endovascular complications.
By Warren Swee, MD, MPH; Jeffrey Y. Wang, MD; and Arthur C. Lee, MD
Outpatient CLI Revascularization in the United States
The benefit of office interventional suites to the complex and at-risk CLI patient.
By Jeffrey Carr, MD; William H. Julien, MD; Arthur C. Lee, MD; Jeffrey Wang, MD; and Lynne Mercadante, RN
Safety in SFA Intervention
By Marianne Brodmann, MD, and John R. Laird Jr, MD
Embolization: Delivering Results
By Jafar Golzarian, MD
Update on Currently Available Bioactive Coils
Polyglycolic acid and hydrogel coatings are being investigated to find the optimal combination of bioactive and platinum coils for intracranial aneurysm treatment.
By Robert D. Ecker, MD, and Lee R. Guterman, MD, PhD
Early Detection of Type I Endoleaks
How we diagnose and treat type I endoleaks by careful evaluation of patients, devices, and imaging modalities.
By Benjamin Colvard, MD, and Jason T. Lee, MD
Training the Next Generation of Aortic Specialists
Future generations of aortic specialists will not only need to master endovascular techniques but also collectively work to preserve the open aortic skill set.
By Eric J. Finnesgard, MD, MS, and Andres Schanzer, MD
Abdominal Aortic Approaches
By Daniel G. Clair, MD, and Timothy A. Resch, MD, PhD
Preclosure for PEVAR
This technique can be applied in a majority of AAA patients.
By Sven R.W. Vercauteren, MD, PhD, and Dominique De Roover, MD
Blunt Thoracic Aortic Injury: Current Issues and Endovascular Treatment Paradigms
The 2011 SVS TEVAR for BTAI clinical guidelines raised a number of unanswered questions. How have they been resolved since then?
By Joshua D. Adams, MD, and John A. Kern, MD
